99 related articles for article (PubMed ID: 24407036)
1. The kinetic mechanism of Human Thymidine Phosphorylase - a molecular target for cancer drug development.
Deves C; Rostirolla DC; Martinelli LK; Bizarro CV; Santos DS; Basso LA
Mol Biosyst; 2014 Mar; 10(3):592-604. PubMed ID: 24407036
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design.
El Omari K; Bronckaers A; Liekens S; Pérez-Pérez MJ; Balzarini J; Stammers DK
Biochem J; 2006 Oct; 399(2):199-204. PubMed ID: 16803458
[TBL] [Abstract][Full Text] [Related]
3. Kinetics mechanism and regulation of native human hepatic thymidine phosphorylase.
Oh T; El Kouni MH
Int J Biochem Cell Biol; 2019 May; 110():122-129. PubMed ID: 30849523
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Escherichia coli GMP reductase: kinetic, catalytic and chemical mechanisms, and thermodynamics of enzyme-ligand binary complex formation.
Martinelli LK; Ducati RG; Rosado LA; Breda A; Selbach BP; Santos DS; Basso LA
Mol Biosyst; 2011 Apr; 7(4):1289-305. PubMed ID: 21298178
[TBL] [Abstract][Full Text] [Related]
5. The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy.
Renck D; Ducati RG; Palma MS; Santos DS; Basso LA
Arch Biochem Biophys; 2010 May; 497(1-2):35-42. PubMed ID: 20226755
[TBL] [Abstract][Full Text] [Related]
6. The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism.
Jain HV; Rasheed R; Kalman TI
Bioorg Med Chem Lett; 2010 Mar; 20(5):1648-51. PubMed ID: 20138520
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants.
Gbaj A; Edwards PN; Reigan P; Freeman S; Jaffar M; Douglas KT
J Enzyme Inhib Med Chem; 2006 Feb; 21(1):69-73. PubMed ID: 16570508
[TBL] [Abstract][Full Text] [Related]
8. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.
Moghaddam A; Bicknell R
Biochemistry; 1992 Dec; 31(48):12141-6. PubMed ID: 1457409
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.
Usuki K; Saras J; Waltenberger J; Miyazono K; Pierce G; Thomason A; Heldin CH
Biochem Biophys Res Commun; 1992 May; 184(3):1311-6. PubMed ID: 1590793
[TBL] [Abstract][Full Text] [Related]
11. Structures of native human thymidine phosphorylase and in complex with 5-iodouracil.
Mitsiki E; Papageorgiou AC; Iyer S; Thiyagarajan N; Prior SH; Sleep D; Finnis C; Acharya KR
Biochem Biophys Res Commun; 2009 Sep; 386(4):666-70. PubMed ID: 19555658
[TBL] [Abstract][Full Text] [Related]
12. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor.
Norman RA; Barry ST; Bate M; Breed J; Colls JG; Ernill RJ; Luke RW; Minshull CA; McAlister MS; McCall EJ; McMiken HH; Paterson DS; Timms D; Tucker JA; Pauptit RA
Structure; 2004 Jan; 12(1):75-84. PubMed ID: 14725767
[TBL] [Abstract][Full Text] [Related]
14. Interdomain twists of human thymidine phosphorylase and its active-inactive conformations: Binding of 5-FU and its analogues to human thymidine phosphorylase versus dihydropyrimidine dehydrogenase.
Tozer T; Heale K; Manto Chagas C; de Barros ALB; Alisaraie L
Chem Biol Drug Des; 2019 Sep; 94(5):1956-1972. PubMed ID: 31356728
[TBL] [Abstract][Full Text] [Related]
15. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
Stevenson DP; Milligan SR; Collins WP
Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068
[TBL] [Abstract][Full Text] [Related]
17. Nucleophilic participation in the transition state for human thymidine phosphorylase.
Birck MR; Schramm VL
J Am Chem Soc; 2004 Mar; 126(8):2447-53. PubMed ID: 14982453
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
[TBL] [Abstract][Full Text] [Related]
19. Kinetic studies of thymidine phosphorylase from mouse liver.
Iltzsch MH; el Kouni MH; Cha S
Biochemistry; 1985 Nov; 24(24):6799-807. PubMed ID: 4074727
[TBL] [Abstract][Full Text] [Related]
20. Role of histidine-85 in the catalytic mechanism of thymidine phosphorylase as assessed by targeted molecular dynamics simulations and quantum mechanical calculations.
Mendieta J; Martín-Santamaría S; Priego EM; Balzarini J; Camarasa MJ; Pérez-Pérez MJ; Gago F
Biochemistry; 2004 Jan; 43(2):405-14. PubMed ID: 14717594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
